Mosaic Therapeutics to Present Poster Highlighting Preclinical Data for Lead Program MOS101 at the American Association for Cancer Research (AACR) Annual Meeting 2026

Contributed by: Business Wire

Logo

Tags

Oncology

Health

Clinical Trials

General Health

Pharmaceutical

Biotechnology

AACR Annual Meeting

More Like This

Merus Announces Abstract Accepted for Presentation at the 2025 ASCO® Annual Meeting

Crown Bioscience Announces New Preclinical and Translational Oncology Data Across Ten Poster Presentations at AACR 2024

Mestag Therapeutics to Present Data on Targeted LTBR Agonist MST-0312 at Cancer Immunotherapy Keystone Symposia

Merus Announces Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting

Incyte to Highlight Early-Stage Oncology Data at American Association for Cancer Research Annual Meeting 2025

Merus Announces Publication of Abstracts for Presentation at the 2024 ASCO® Annual Meeting

Brenus Pharma Presented New Preclinical and Early Clinical Data in Colorectal Cancer During AACR Immuno-Oncology Conference 2026

Mosaic Therapeutics appoints Dr Vince O'Neill, MD, as Head of R&D